News about Global Pharma

Akums to Set Up Manufacturing Facility in Zambia

Akums Drugs and Pharmaceuticals has signed a framework agreement with the Government of the Republic of Zambia to establish a local manufacturing facility in the country and supply essential medicines.

Global Pharma | 25/08/2025 | By Dineshwori |  300

Gyre Therapeutics Appoints Dan Weng to Board of Directors

Gyre Therapeutics, a US-based commercial-stage biopharmaceutical company focused on innovative therapies for organ fibrosis, has announced the appointment of Dr. Dan Weng, former CEO of Medelis, to its Board of Directors.

Global Pharma | 22/08/2025 | By Dineshwori |  203

ANGLE Forms Strategic Collaboration with Myriad Genetics

ANGLE plc has entered into a collaboration with Myriad Genetics to evaluate circulating tumour cell DNA using ANGLE’s Parsortix system alongside Myriad’s tissue-based assays, aiming to advance precision oncology.

Global Pharma | 22/08/2025 | By Mrinmoy Dey |  141

Alvotech and Advanz Pharma Secure European Approval for Eylea Biosimilar Mynzepli

Alvotech and its commercial partner Advanz Pharma have announced that the European Commission has granted marketing authorisation for Mynzepli (aflibercept), a biosimilar to Eylea, available in both pre-filled syringes and vials.

Global Pharma | 22/08/2025 | By Dineshwori |  202

BioMed X and Novo Nordisk Partner to Advance Oral Peptide Drug Delivery

BioMed X and Novo Nordisk’s partnership aims to address one of the most critical challenges in modern drug development: the efficient oral delivery of therapeutic peptides.

Global Pharma | 21/08/2025 | By Dineshwori |  598

LSPedia Partners with Spring Bio Solution to Advance Pharma Traceability in India

LSPedia has partnered with India-based Spring Bio Solution to expand global adoption of its OneScan pharmaceutical compliance and track-and-trace platform.

Global Pharma | 21/08/2025 | By Mrinmoy Dey |  222

NATCO Launches Tracleer Generic in US with Lupin

NATCO Pharma has announced the launch of Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc., in partnership with Lupin.

Global Pharma | 20/08/2025 | By Dineshwori |  324

Alembic Pharma Receives USFDA Final Approval for Macitentan Tablets, 10 mg

Alembic Pharmaceuticals Ltd. has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Macitentan Tablets, 10 mg.

Global Pharma | 20/08/2025 | By Dineshwori |  396

Senores Pharmaceuticals Appoints Manohar Lalge as President - Research & Development

Senores Pharmaceuticals Ltd. (SPL) has appointed Manohar Lalge as President – Research and Development.

Global Pharma | 20/08/2025 | By Dineshwori |  388

Pharma sector braces for tariff risks as US steps up trade actions: Report

India’s pharmaceutical industry may face fresh tariff challenges as the United States intensifies trade actions, according to a recent report. The development has raised concerns among Indian drugmakers, who already account for a significant share of the generic medicines supplied to the US market.

Global Pharma | 20/08/2025 | By Darshana |  209